Company / Depreciation & Amortization
NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation & Amortization History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$246.8K
FY2025
5-year range
$47.6K / $246.8K
FY2021-FY2025
Trend
+23.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 4 consecutive years, from $47,609 in FY2021 to $246,791 in FY2025.
Based on SEC 10-K filings.
$246,791 in FY2025 with a 3-year CAGR of +45.1%.
Increased from $118,620 to $246,791 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +45.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +45.1%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 23.9% year-over-year.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $246.8K | +23.9% |
| FY2024 | $199.3K | +68.0% |
| FY2023 | $118.6K | +46.9% |
| FY2022 | $80.7K | +69.6% |
| FY2021 | $47.6K | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026